| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $236.7M | +9.5% |
| Cost of Revenue | $89.5M | +14.0% |
| Gross Profit | $147.2M | +7.0% |
| R&D Expense | $49.9M | +8.7% |
| SG&A Expense | $27.8M | +0.0% |
| Operating Income | -$4.0M | +30.5% |
| Pre-tax Income | -$2.8M | +48.1% |
| Income Tax | -$2.0M | -11.8% |
| Net Income | -$835K |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | -27.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $9.9M | +38.3% |
| Inventory | $19.8M | -24.6% |
| Current Assets | $63.7M | -14.6% |
| Total Assets | $159.3M | +21.6% |
| Current Liabilities | $51.5M | -10.3% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.3M | +39.9% |
| Capital Expenditures | $6.2M | +18.2% |
| Investing Cash Flow | -$35.3M | -474.8% |
| Financing Cash Flow | $16.5M | +792.8% |
| Free Cash Flow | $6.1M | +71.6% |
| +77.2% |
| EPS (Basic) | -$0.03 | +80.0% |
| EPS (Diluted) | -$0.03 | +80.0% |
| Long-term Debt |
| $16.0M |
| — |
| Total Liabilities | $81.2M | +19.6% |
| Stockholders' Equity | $78.1M | +23.7% |